Viewing Study NCT00453193


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-04-09 @ 6:29 PM
Study NCT ID: NCT00453193
Status: TERMINATED
Last Update Posted: 2012-08-07
First Post: 2007-03-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Alemtuzumab and Pentostatin In T-cell Neoplasms
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T-Cell Neoplasms View
None Alemtuzumab View
None Pentostatin View
None Campath-1H View
None Deoxycoformycin View
None Lymphoma View
None Leukemia View